No Data
No Data
Rocket Pharmaceuticals(RCKT.US) Officer Sells US$61,715.27 in Common Stock
$Rocket Pharmaceuticals(RCKT.US)$ Officer White Mark Andrew sold 3,026 shares of common stock on Jul 8, 2024 at an average price of $20.395 for a total value of $61,715.27.Source: Announcement What
Rocket Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Rocket Pharmaceuticals Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $40
CCORF Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Cuts Target Price to $40
CCORF analyst Whitney Ijem maintains $Rocket Pharmaceuticals(RCKT.US)$ with a buy rating, and adjusts the target price from $49 to $40.According to TipRanks data, the analyst has a success rate of 47.
Express News | Rocket Pharmaceuticals Inc : Canaccord Genuity Cuts Target Price to $40 From $49
Express News | Rocket Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $46 From $49